Emerald Health Therapeutics Inc
F:TBD
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TBD's stock price target?
Not Available
TBD doesn't have any price targets made by Wall Street professionals.
What is Emerald Health Therapeutics Inc's Revenue forecast?
Projected CAGR
290%
For the last 5 years the
compound annual growth rate for
Emerald Health Therapeutics Inc's revenue is
107%.
The projected
CAGR
for the next 1 year is
290%.